Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;27(5):2891-2895.
doi: 10.1111/dom.16287. Epub 2025 Mar 3.

Effect of tirzepatide on weight and metabolism in a multiethnic cohort with and without diabetes

Sara El Ghandour  1   2 , Fatemeh Akbarpoor  1 , Momina Malik  1 , Madeeha Kalsekar  1 , Sara Vidha  1 , Prisha Bhatia  1 , Nisrine Al Ghazal  1   2 , Jeyaseelan Lakshmanan  1 , Rabia Cherquaoui  2 , Farah Al Abed  2 , Mona Jomaa  2 , Georges Hajje  1   2 , Samuel B Ho  1   2 , Maryam Alsaeed  1   2
Affiliations

Effect of tirzepatide on weight and metabolism in a multiethnic cohort with and without diabetes

Sara El Ghandour et al. Diabetes Obes Metab. 2025 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MAS has served on ad‐hoc advisory boards and has received speaker honoraria from Eli Lilly.

References

    1. Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223‐1249. doi:10.1016/S0140-6736(20)30752-2 - DOI - PMC - PubMed
    1. Mamdouh H, Hussain HY, Ibrahim GM, et al. Prevalence and associated risk factors of overweight and obesity among adult population in Dubai: a population‐based cross‐sectional survey in Dubai, The United Arab Emirates. BMJ Open. 2023;13(1):e062053. doi:10.1136/bmjopen-2022-062053 - DOI - PMC - PubMed
    1. Al Awadi F, Hassanein M, Hussain HY, et al. Prevalence of diabetes and associated health risk factors among adults in Dubai, United Arab Emirates: results from Dubai household survey 2019. Dubai Diabetes Endocrinol J. 2020;26(4):164‐173. doi:10.1159/000512428 - DOI
    1. Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6(2):187‐194. doi:10.1007/s13679-017-0262-y - DOI - PMC - PubMed
    1. Nauck MA, Müller TD. Incretin hormones and type 2 diabetes. Diabetologia. 2023;66(10):1780‐1795. doi:10.1007/s00125-023-05956-x - DOI - PMC - PubMed

LinkOut - more resources